+34934182331 info@freelancecra.com

“The content was very detailed and informative.

The exam challenged my knowledge and invested effort. It was a good test of my experience…”

Jonathan M.

Senior CRA

FCRA partners with PharmaSchool to offer our network the best on-line training possible. PharmaSchool is one of the most well-respected clinical research training organizations in the world. Established in 2005 by industry experts their philosophy is to provide excellent training which meets customers’ needs.

PharmaSchool Flexible Online Learning provides a wide range of modules and packages that are suitable for people currently working in clinical research or those who are seeking to enter the industry. PharmaSchool has thousands of users from over 70 countries worldwide.

Set your target for professional development

  • As a CRA contracted via FCRA Network, these modules are offered to you free of charge to keep up to date with your professional development goals and GCP compliance.
  • As a Senior CRA registered with FCRA Network, these packages come at a preferential rate.
GCP and Essential Guidelines

Description

There are a wide range of guidelines and regulations in clinical research. This module introduces the background and history to clinical research guidelines and regulations and explains the difference between a guidelines and a regulation. The module progresses by looking in detail at the relevant guidelines and regulations and provides an essential foundation for anyone involved or wanting to be involved in clinical research. The content is the same as the ICH GCP Certificate with the addition of US and EU Guidelines.

Who is the Module Designed For?

The course is also essential for anyone working in clinical research and clinical trials who is not familiar with the guidelines and regulations they should be following. This course is designed for anyone wishing to pursue a career in clinical research (including the roles of CRA, CTA, study nurse) whether in a pharmaceutical company, contract research organisation or in a health service/academic setting. The course provides certification of the completion of GCP and Essential Guidelines Training.

Course Content

Background

History of Clinical Trial Legislation
Code of Federal Regulations
ICH GCP

Overview of ICH GCP

Roles and Responsibilities
IRB/IEC
Investigator
Sponsor
Monitor
Protocol and amendments
Investigators Brochure
Essential Documents
Ultimate responsibilities under ICH

Europe

EU Clinical Trials Directive
EU GCP Directive
GMP Directive and Annexe 13

The USA

FDA Code of Federal Regulations Title 21 Part 312
FDA 21 CFR part 11

What Prior Knowledge is Needed?

It is useful but not essential to have completed the module Introduction to Clinical Research. This previous module provides a good overview of the industry and the various stages of clinical research.

Monitoring

Description

There are numerous tasks that a monitor must be able to fulfil within their role, these range from selecting, initiating, routine monitoring and closing out sites through to managing investigators, building relationships and problem solving. There are a multitide of regulations and guidelines that a monitor needs to be aware of whilst fulfilling their role. This module blends theory together with practical hints and tips to provide an essential course for a new or potential CRA/Monitor.

Who is the Module Designed For?

The module is designed for anyone who is new to the role of a monitor or is seeking a position as a CRA/Monitor in either the commercial or non-commercial setting. The module provides the essential foundation to monitoring and contains a practical monitoring exercise to put what you have learned from the module into practice.

Course Content

Introduction

Monitoring Basics
What is Monitoring?
Who can be a Monitor?
Knowledge, Skills and Attitudes required
How much monitoring?
Types of Monitoring Visit

Site Selection

Before the visit
During the visit
After the Visit

Site Initiation

Before the visit
During the visit
After the visit

Routine Monitoring

Before the visit
During the visit
After the visit

Site Closeout

Before the Visit
During the Visit
After the Visit
Report and Letter Writing

What Prior Knowledge is Needed?

This module covers the essential requirements and skills for monitoring clinical research in medicinal products. It does not cover the drug development process, the clinical trial process or the regulatory requirements except for those specifically related to monitoring. It is recommended that if you are not familiar with these areas that you take these modules.

Clinical Trial Designs

Description

There are numerous related components that make up a clinical trial design. These range from the data to capture, the number of patients, randomisation and blinding through to matters such as whether the trial is looking to show equivalence or a difference between treatment groups.

This online module goes through the various components and details the various aspects and considerations of each one. The module explains among other matters the difference between parallel group and cross over trials, single, double and triple blinding, sample size considerations, and difference vs non-inferiority.

Who is it suitable for?

The module is designed for people currently working in clinical research in roles such as CTA, CRA, Regulatory Affairs, Investigators and Nurses, Project Managers, Data Managers and Medical Communication/Information positions.

The module is also suitable for individuals either new to the industry or wishing to join the industry as it provides an excellent insight into clinical trial design

Course Content

Background

Confounding
Trial Objectives
Data & Endpoints

Fundamental Trial Designs

Parallel Group Trial
Cross Over Trial
Non-Comparative Trial

Randomisation

Stratification
Minimisation

Blinding & Masking

Open-Label Trial
Single Blind
Double Blind
Double Dummy
Triple Blind

Comparator

Different comparators
Selecting the comparator

Type of Comparison

Difference Comparison
Non-Inferiority
Equivalence

How Many Subjects?

Power and Sample Size
Populations

What Prior Knowledge is Needed?

It is useful to have an overview of the clinical trial process but this is not essential. This knowledge can be obtained by taking the module entitled Introduction to Clinical Research.

Introduction to Clinical Research

Description

Getting a new pharmaceutical product to market involves a large amount of investment and a great deal of time. The module introduces the pharmaceutical industry and provides an informative overview of the stages of developing a new pharmaceutical product. The module then looks at the stages involved in the clinical testing of the new product by explaining the different types of clinical trials, the different phases of trials and the personnel involved in clinical research.

Who is the Module Designed For?

The module is designed for people who are new to clinical research, for administrators working in the area who would like to learn more about the environment in which they work. and for those who are considering a move into clinical research (for example wanting to become a CRA, CTA, data manager) whether it be in a pharmaceutical company, contract research organisation or in a health service/academic setting.

Course Content

Background to the Industry

The Industry Today New Product Development Patent Protection

Product Discovery

Preclinical Development & Chemistry Chemistry & Manufacturing Considerations Clinical Development/Clinical Research

Stages of Clinical Research

Phase I & Early Stage Clinical Research Phase II Phase III Late Phase Phase IIIb Phase IV Post Marketing Surveillance (PMS) Generic Products

Overview of Process for a Clinical Trial

Protocol Obtain Relevant Approvals Design Case Report Form (CRF) Product Supply Recruit, Manage & Monitor Subjects/Patients Data Management Analyse & Report Data

Organisations involved in clinical research

What Prior Knowledge is Needed?

None

GMP for IMPs

Description:

This online module will provide an understanding of Good Manufacturing Practice requirements for Investigational Medicinal Products and practical guidelines for ensuring GMP is followed at site

Who it is suitable for:

The course is aimed at anyone involved in the supply and management of IMP for investigational sites, e.g. CRA/Monitor responsible for monitoring investigator sites. The course is specifically relevant for

CTAs CRAs Project Managers Pharmacists Investigators

Course Contents

Introduction to GMP Annexe 13 of Eudralex Vol 4 Quality Management Documentation Production Relabeling QC Batch Release QP Release Exemption Shipping Storage, Dispensing and Accountability Return and Destruction Responsibilities: Sponsor, Investigator and QP

ICH GCP Certificate

Description

There are a wide range of guidelines and regulations in clinical research. This module is designed for those individuals who require a documented knowledge of ICH GCP. The Course Manual guides you through ICH GCP in preparation for the examination. Successful completion (pass mark is 60%) of the exam will earn you an ICH GCP Certification. The manual and the examination are all included within the one price.

Who is the Module Designed For?

The course and certification is for anyone who needs ICH GCP Certification for their job role or prospective career. The content is the same as the GCP and Essential Guidelines Module with the exception of US and EU Guidelines not being included in this. The ICH GCP Certificate is popular throughout the World and is a recognised method of achieving the certification required to work in a GCP environment.

Course Content

Background

History of Clinical Trial Legislation
ICH GCP

Overview of ICH GCP

Roles and Responsibilities
IRB/IEC
Investigator
Sponsor
Monitor
Protocol and amendments
Investigators Brochure
Essential Documents
Ultimate responsibilities under ICH

Examination and Certification

2015 GCP Certificate

Description

There are a wide range of guidelines and regulations in clinical research. GCP certification needs to be updated every year or two years depending on the region in which you work. This module is for those who have already taken ES2: GCP & Essential Guidelines but wish to update their certification. The module contains the Course Manual for the GCP Course to allow you to revise GCP together with an examination. The examination is different to that of the GCP & Essential Guidelines Course.

Who is the Module Designed For?

This module is designed for those who have previously completed the GCP & Essential Guidelines (or ICH GCP Certificate) Course and require an updated certificate in GCP. The course provides certification of the completion of GCP and Essential Guidelines Training.

Course Content

Background

History of Clinical Trial Legislation
Code of Federal Regulations
ICH GCP

Overview of ICH GCP

Roles and Responsibilities
IRB/IEC
Investigator
Sponsor
Monitor
Protocol and amendments
Investigators Brochure
Essential Documents
Ultimate responsibilities under ICH

Europe & The USA

CRA Development & Education Certificate

Background

This CRA Development and Education Certificate (CRADEC) is a Globally Recognised Certificated Course developed to provide a complete, cost-effective training package for those new to the CRA role or looking to move into this role in the near future. The Course has been developed from the hugely successful PharmaSchool Ultimate CRA Development Programme which has been used for several years by a large number of individual and corporate users.

Certification

A certificate is awarded for the successful completion of the Course. The examination is taken online and comprises of 50 multiple choice questions. The certificate contains a unique Certificate Validation Code that allows you to provide this to prospective or current employers to validate your completion of the Course.

Contents:

Introduction to Clinical Research

Getting a new pharmaceutical product to market involves a large amount of investment and a great deal of time. The section introduces the pharmaceutical industry and provides an informative overview of the stages of developing a new pharmaceutical product. The section continues to then look at the stages involved in the clinical testing of the new product by explaining the different types of clinical trials, the different phases of trials and the personnel involved in clinical research.

ICH GCP

There are a wide range of guidelines and regulations in clinical research. This section introduces the background and history to clinical research guidelines and regulations and explains the difference between a guidelines and a regulation. The section progresses by looking in detail at the relevant guidelines and regulations and provides an essential foundation for the CRA.

Clinical Trial Designs

There are numerous related components that make up a clinical trial design. These range from the data to capture, the number of patients, randomisation and blinding through to matters such as whether the trial is looking to show equivalence or a difference between treatment groups. The section explains among other matters the difference between parallel group and cross over trials, single, double and triple blinding, sample size considerations, and difference vs non-inferiority.

Monitoring

There are numerous tasks that a monitor must be able to fulfil within their role, these range from selecting, initiating, routine monitoring and closing out sites through to managing investigators, building relationships and problem solving. There are a multitide of regulations and guidelines that a monitor needs to be aware of whilst fulfilling their role and this section works through all of these.

Essential Documents

There is a saying in clinical research that “if it’s not documented it didn’t happen”. This means that documentation is critical to the trial and setting up and maintaining good files is a key part of running and clinical trial. This section covers all the documents required for regulatory purposes along with practical information.

Course Manual

The Course is based around a pdf course manual/book which extends to over 140 pages. Unlike many courses this is not a set of powerpoint slides, instead this is a comprehensive book which also includes reference to the PharmaSchool Learning Management Centre which hosts the online aspects of the Course.

Pharmacovigilance for Clinical Trials

Description

Adverse Event collection and reporting is a critical aspect of conducting clinical trials in accordance with GCP. This module provides information and guidance on collection, review andreporting requirements in accordance with ICH, EMA and FDA legislation andguidance. The module covers reporting for clinical trials, annual safety updates during drug development and alsopost-marketing pharmacovigilance requirements.

Who is the Module Designed For?

The course is designed for anyone who has responsibilities foradverse event identification, collection, review or reporting. This  includes medical advisors, investigators, pharmacovigilance staff, project managers, CRAs, data managers and medical writers.

Course Content

Definitions and terminologies used in pharmacovigilance
Adverse Events Reporting in Clinical Trials

Sponsors Responsibilities
Reporting Time Frames
Minimum criteria for reporting
How to report
Informing Investigators and Ethics committees of new safety
information
Development Safety Update Report

Post Marketing Pharmacovigilance

Unsolicited Sources
Solicited Sources
Contractual Agreements
Spontaneous reporting – requirements and timelines
Periodic Safety Update Report

What Prior Knowledge is Needed?

An understanding of the drug development and clinical trials processes would be very helpful. The PharmaSchool modules “Introduction to Clinical Research” and/or “GCP and Essential Guidelines” would provide this knowledge.

GCP for Investigators and Investigational Site Staff

Description

This ICH E6 GCP Investigator Site Training meets the Minimum Criteria for ICH GCP Investigator Site Personnel Training identified by TransCelerate BioPharma as necessary to enable mutual recognition of GCP training among trial sponsors.

The investigational site has a key role to play in clinical research. This module introduces the clinical trials process and covers the key GCP requirements and responsibilities for investigators and investigational site staff. The module also covers other relevant guidelines and regulations and provides an essential foundation for anyone involved or wanting to be involved in clinical research.

Who is the Module Designed For?

The course is essential for investigators and investigational site staff working in clinical research and clinical trials, particularly those who are not familiar with the guidelines and regulations they should be following. The course provides certification of the completion of GCP for Investigators and Investigational Site Staff Training.

Course Content

Introduction to Clinical Development/Clinical Research

Objectives of Clinical Research
What is a clinical trial?
Stages of Clinical Research
Generic Products

Background to Clinical Trials Regulation

ICH GCP

Overview and principles of ICH GCP
Roles and Responsibilities, with emphasis on investigator responsibilities
Protocol and amendments
Investigators Brochure
Essential Documents

EUROPE

Eudralex Volume 10
EU Clinical Trials Directive
EU GCP Directive
GMP Directive and Annexe 13
EU Guidelines and Recommendations

THE USA

FDA Code of Federal Regulations Title 21
FDA CFR 21 Part 312
FDA 21 CFR part 11

Audit and Inspection

Fraud and Misconduct

What Prior Knowledge is Needed?

No prior knowledge is necessary, this module covers the key aspects investigators and investigational site staff need to be aware of.

For more information

Contact FCRA Network